As of 2026-04-02, the Relative Valuation of Zealand Pharma A/S (ZEAL.CO) is 1,009.55 DKK. This relative valuation is based on P/E multiples. With the latest stock price at 295.00 DKK, the upside of Zealand Pharma A/S based on Relative Valuation is 242.2%.
The range of the Relative Valuation is 872.91 - 1,116.51 DKK.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 11.6x | 11.4x |
| Forward P/E multiples | 8.6x - 11.0x | 9.8x |
| Fair Price | 872.91 - 1,116.51 | 1,009.55 |
| Upside | 195.9% - 278.5% | 242.2% |
| Date | P/E |
| 2026-04-01 | 3.36 |
| 2026-03-31 | 3.27 |
| 2026-03-30 | 3.26 |
| 2026-03-27 | 3.19 |
| 2026-03-26 | 3.19 |
| 2026-03-25 | 3.19 |
| 2026-03-24 | 3.11 |
| 2026-03-23 | 3.10 |
| 2026-03-20 | 3.19 |
| 2026-03-19 | 3.10 |
| 2026-03-18 | 3.11 |
| 2026-03-17 | 3.30 |
| 2026-03-16 | 3.14 |
| 2026-03-13 | 2.97 |
| 2026-03-12 | 2.91 |
| 2026-03-11 | 2.99 |
| 2026-03-10 | 2.88 |
| 2026-03-09 | 2.83 |
| 2026-03-06 | 2.60 |
| 2026-03-05 | 4.09 |
| 2026-03-04 | 4.12 |
| 2026-03-03 | 3.95 |
| 2026-03-02 | 4.07 |
| 2026-02-27 | 4.03 |
| 2026-02-26 | 3.99 |
| 2026-02-25 | 3.98 |
| 2026-02-24 | 4.05 |
| 2026-02-23 | 4.19 |
| 2026-02-20 | 4.35 |
| 2026-02-19 | 4.24 |
| 2026-02-18 | 4.39 |
| 2026-02-17 | 4.30 |
| 2026-02-16 | 4.32 |
| 2026-02-13 | 4.43 |
| 2026-02-12 | 4.53 |
| 2026-02-11 | 4.47 |
| 2026-02-10 | 4.64 |
| 2026-02-09 | 4.61 |
| 2026-02-06 | 4.51 |
| 2026-02-05 | 4.43 |
| 2026-02-04 | 4.77 |
| 2026-02-03 | 4.81 |
| 2026-02-02 | 4.74 |
| 2026-01-30 | 4.65 |
| 2026-01-29 | 4.56 |
| 2026-01-28 | 4.54 |
| 2026-01-27 | 4.73 |
| 2026-01-26 | 4.63 |
| 2026-01-23 | 4.72 |
| 2026-01-22 | 4.81 |